The Solarea breakthrough came from the combined efforts of the company’s co-founders who established a link between the discovery of an untapped source of microorganisms with probiotic potential in healthy foods, and their applications in inflammatory processes including the gut-musculoskeletal axis.

The first application aims to address the metabolic processes of osteopenia and osteoporosis in postmenopausal women where diet alone is not sufficient to maintain a healthy skeleton and natural alternatives are desired over conventional pharmaceuticals

Solarea Bio

  • Solarea Bio means effective products based on strong scientific and clinical evidence.
  • Solarea Bio means understanding the interactions between our body and the microbes in our foods and how they can be harnessed for health.
  • Solarea Bio means using food as Medicine™.

Our Team

Gerardo V Toledo, Ph.D.

Co-Founder and CEO

A microbial ecologist turned entrepreneur, for the last 20 years has been leading high output teams during the early stages of Diversa Corp. (now BASF), Synthetic Genomics, Indigo Ag, and founder of Solarea Bio. He has been at the front of the company from a brainstorm with friends to a successful preclinical stage and now entering into a clinical validation of the effect specific combinations of microbes and plant fibers can have on health management. He likes the outdoors enjoying mountain biking and have completed 3 ironman races.

Eric Schott, Ph.D.

Co-Founder and Vice President for Translational Research and Operations

As a graduate student at the University of Rochester Medical School, Eric Pioneered studies aimed at defining the role of the gut microbiome in the induction of osteoarthritis and other musculoskeletal conditions influenced by obesity and type 2 diabetes as comorbid factors. This work set the stage for Solarea’s initial focus on musculoskeletal health, where Eric now leads the preclinical and translational development of Solarea products. Outside of work, he enjoys traveling, hiking, and spending time with his family and friends.

David Easson Jr., Sc.D.

Chief Manufacturing Officer

David Easson is currently Chief Manufacturing Officer at Solarea Bio.  He has over 25 years experience in the biotech industry in both private and public sectors.  Prior to joining Solarea, David built and led process development and manufacturing functions at Indigo Ag, AOBiome, Epic Therapeutics / Baxter Healthcare, Collaborative BioAlliance and Alpha-Beta Technology.  He is currently a board member of Massachusetts Biomedical Initiatives, a biotech incubator and previously served on the boards of the UMass Memorial Medical Center Foundation, the Worcester Business Development Corporation and the Bay State Chapter of the Juvenile Diabetes Research Foundation (JDRF).  He also served as a research grant review committee member for JDRF International.  David has a B.S. in chemical engineering from the University of South Carolina and a Sc.D. in biochemical engineering from MIT.

Thomas Ishoey, Ph.D.

Head of Microbial Genomics

Thomas is a passionate and innovative technologist with expertise in early stage technology development and commercialization. Thomas has held C-level management positions with demonstrated turn-around and team building capability across multiple disciplines. He brings deep experience in evaluating technology concepts and implementation plans, fundraising, and has experience in biology, genomics and engineering including industrial and subsurface applied microbiology and biotechnology.

Greg Sieczkiewicz, Ph.D., J.D.

Chief IP Counsel

Greg is a trusted intellectual property strategy advisor for entrepreneurs, venture capital firms, emerging start-ups, and public biotech/pharmaceutical companies. Over the past 20 years, he has contributed to the creation, execution, assertion and defense of strategic legal plans for a diverse array of biotechnology companies. In addition, he has been the front line agreement negotiator and drafter for licensing, development and commercialization agreements relating to biologics and small molecules from pre-IND to approved drugs. Greg was awarded a PhD in cell, molecular and developmental biology from the Tufts Graduate School of Biomedical Sciences, a law degree from Suffolk University Law School, and an undergraduate degree from the College of the Holy Cross. Greg has been affiliated with top law firms including Mintz Levin, Proskauer Rose, and Foley Hoag. Greg is currently the Chief IP Counsel at MPM Capital, and was previously Vice President of IP at Flagship Pioneering.

Juliana Soto, Ph.D.

Translational Bioinformatics Lead

A Colombian Scientist building a career in healthcare, entrepreneurship, and innovation. At Solarea Bio, she leads the Bioinformatics core and develops the strategy for projects related to microbiome biomarker discovery and genome mining. She also built and manages the company’s cloud-based computing infrastructure. Juliana is committed to advocating and inspiring girls from underrepresented communities to reach their potential in the STEM fields. She loves dancing salsa, hiking, and cycling.

Claudine Tahmin

Senior Research Associate

Originally from New York, Claudine moved to Boston and graduated from Northeastern University with a B.S. in Biology and a minor in environmental science. At Solarea Bio, she is involved in many facets of the Discovery Team and manages all operational aspects of the lab. She hopes to pursue a PhD in Plant Biology. In her free time, Claudine enjoys backpacking and being outside.

Maeve Pattie


Maeve grew up in Newburyport, Massachusetts and has interned with Solarea Bio during the summers of 2019 and 2020. She is entering her senior year at Wesleyan University in Middletown, Connecticut, where she is earning major certificates in Biology and Hispanic Literature and Cultures and a minor certificate in Integrative Genomic Science. After graduation this Spring, she hopes to work towards a PhD in Bioinformatics or Integrative Genomics and pursue a career in biotechnology.

Scientific Advisory Board

Susan Bukata, MD

Michael Zuscik, PhD

Douglas P. Kiel, MD, MPH

Clifford Rosen, MD

Board of Directors

Anula Jayasuriya, MD, PhD, MBA

Matthew Walker, J.D., MBA

Neal Bhadkamkar, Ph.D., MBA

Gerardo V Toledo, Ph.D.

Greg Sieczkiewicz, Ph.D., J.D.


Our Values


Trust and

Scientific rigor

and inclusion



of Purpose